More Articles

March 25, 2019 | Vascular & Endovascular

While accident victims in the U.S. are uniformly taken directly to the most advanced trauma center nearby, the protocols for where to shuttle stroke patients vary widely by state, according to a recent…

fda-logo-large_900x550.jpg
March 15, 2019 | Vascular & Endovascular

The FDA’s preliminary investigation into the long-term safety of paclitaxel-coated balloons and stents revealed those devices are associated with a 50 percent higher risk of death than control devices used to treat femoropopliteal artery…

Pollution
March 13, 2019 | Vascular & Endovascular

Air pollution could be contributing to twice as many deaths as previously estimated, according to research published in the

March 06, 2019 | Vascular & Endovascular

The Early Bird Bleed Monitoring System, which can detect internal bleeding during endovascular procedures, has been granted de novo classification by the FDA. The approval was…

March 04, 2019 | Vascular & Endovascular

Despite living in a country with universal healthcare, Canadians residing in rural areas have more vascular risk factors and a higher incidence of stroke, even after adjusting for comorbidities and sociodemographic conditions.

February 27, 2019 | Vascular & Endovascular

A small-scale study out of Germany has concluded thrombectomy—an already proven treatment for large intracranial vessel occlusions in adults—is also safe in children.

Childhood stroke is rare, with an estimated…

February 26, 2019 | Vascular & Endovascular

When endovascular thrombectomy procedures for acute ischemic stroke take more than an hour or require more than three attempts to remove the clot, outcomes significantly worsen, according to a…

February 26, 2019 | Vascular & Endovascular

The FDA issued a safety alert Feb. 25 warning that a 10 mg, twice-daily dose of tofacitinib—sold under the brand names Xeljanz…

Cheryl Petersilge, MD, MBA, with the department of regional radiology at the Cleveland Clinic, examined enterprise imaging—and how radiologists must integrate and collaborate with other departments. Her clinical perspective clinical perspective was published online in the October issue of the American Journal of Roentgenology.
February 20, 2019 | Vascular & Endovascular

In the latest twist in the debate over the long-term safety of paclitaxel-coated balloons and stents, a correction published Feb. 19 in Circulation said the…

February 20, 2019 | Vascular & Endovascular

A startup that sold young donors’ blood to consumers in several states with the goal of treating conditions such as dementia, Alzheimer’s disease and heart disease has apparently shut down in the wake of an…

Adults who regularly drink sweetened beverages face a heightened risk of atrial fibrillation (AFib), according to new data published in Circulation: Arrhythmia and Electrophysiology.
February 19, 2019 | Vascular & Endovascular

Women who consumed multiple artificially sweetened beverages per day, including diet sodas and fruit drinks, were significantly more likely to die or suffer ischemic strokes over an average follow-up period of 12 years, according to an…

February 15, 2019 | Vascular & Endovascular

Physiological age based on exercise performance is a better predictor of long-term survival than chronological age, according to a study of more than 126,000 patients at the Cleveland Clinic.

Lead author Serge C. Harb…

Medtronic IN.PACT Admiral drug-coated balloon (DCB)
February 14, 2019 | Vascular & Endovascular

Paclitaxel-coated devices were found safe for the treatment of femoropopliteal artery revascularization in a

Diet Time
February 13, 2019 | Vascular & Endovascular

A study of health outcomes among more than 1 million men who enlisted in the Swedish Armed Forces decades ago has thrown into sharp relief the connection between poor health habits in adolescence and chronic…

February 12, 2019 | Vascular & Endovascular

Home-based telerehabilitation is just as effective as traditional rehab for restoring arm function in stroke survivors, according to late-breaking science presented at this year’s American Stroke Association International Stroke…

February 07, 2019 | Vascular & Endovascular

The FDA announced Feb. 6 it has approved Cablivi (caplacizumab-yhdp) for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP…

February 07, 2019 | Vascular & Endovascular

Hospitals participating in the second phase of a quality improvement program through the American Heart Association/American Stroke Association (AHA/ASA) reduced their median door-to-needle times for acute ischemic stroke patients from 66…

E-cig. Using e-cigarettes may be associated with a heightened risk of atrial fibrillation (AFib) or other heart rhythm issues, according to new research published in Nature Communications.
February 04, 2019 | Vascular & Endovascular

E-cigarette users can now add stroke to the list of risks they incur when they make the choice to vape, according to a study of more than 400,000 Americans.

Research slated for presentation Feb. 6 at the American…

January 30, 2019 | Vascular & Endovascular

A study of Native Americans who experienced ischemic stroke showed they carried a high burden of risk factors, nearly all of which grew in prevalence from 2000 to 2016.

Previous research has shown Native Americans have…

The World Health Organization (WHO) has officially endorsed the use of polypills—fixed combinations of multiple medicines contained in a single pill—for the prevention of cardiovascular disease, adding them to the latest edition of the WHO Model List of Essential Medicines.
January 30, 2019 | Vascular & Endovascular

Direct oral anticoagulants (DOACs) are on their way to surpassing warfarin as the anticoagulant of choice among Medicaid beneficiaries, despite their higher cost, according to new…